Refer an Adult Patient

Yescarta (axicabtagene ciloleucel) CAR T-cell therapy is available for patients with: 

  • Large B-cell lymphoma after at least two other kinds of treatment failed, including:
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Primary mediastinal large B-cell lymphoma
    • High grade B-cell lymphoma
    • DLBCL arising from follicular lymphoma

Find a cellular therapy clinical trial underway at UChicago Medicine. 

To refer a patient to our CAR T-cell therapy program, please call 1-844-482-7823.

 

Refer a Pediatric Patient

Kymriah (tisagenlecleucel) CAR T-cell therapy is available for patients with: 

  • Primary refractory B-cell pediatric acute lymphoblastic leukemia (ALL)
  • Relapsed or refractory B-cell ALL
  • Relapsed B-cell ALL

To refer a patient to our CAR T-cell therapy program, please call 1-844-482-7823.

Clinical Trials of New Cellular Therapies

Our physicians work to bring the latest breakthroughs in cellular therapy treatments quickly to their patients’ bedsides. Several new cellular therapies are now being tested through clinical trials for blood cancers and solid tumors.

Convenient Locations for Cancer Care